Financial reports
ARS
2023 FY
Annual report to shareholders
18 Apr 24
10-K
2023 FY
Annual report
22 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
17 Apr 23
10-K
2022 FY
Annual report
23 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
Current reports
8-K
Other Events
15 Apr 24
8-K
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
21 Mar 24
8-K
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
20 Mar 24
8-K
TELA Bio Reports Third Quarter 2023 Financial Results
9 Nov 23
8-K
Entry into a Material Definitive Agreement
20 Oct 23
8-K
Departure of Directors or Certain Officers
28 Sep 23
8-K
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
16 Aug 23
8-K
TELA Bio Reports Second Quarter 2023 Financial Results
9 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 23
8-K
TELA Bio Reports First Quarter 2023 Financial Results
11 May 23
Registration and prospectus
S-8
Registration of securities for employees
22 Mar 24
S-3
Shelf registration
13 Nov 23
424B5
Prospectus supplement for primary offering
20 Apr 23
424B5
Prospectus supplement for primary offering
18 Apr 23
S-8
Registration of securities for employees
23 Mar 23
424B5
Prospectus supplement for primary offering
17 Aug 22
424B5
Prospectus supplement for primary offering
15 Aug 22
S-8
Registration of securities for employees
23 Mar 22
S-3
Shelf registration
18 Dec 20
S-8
Registration of securities for employees
13 Aug 20
Proxies
DEFA14A
Additional proxy soliciting materials
18 Apr 24
DEF 14A
Definitive proxy
18 Apr 24
DEFA14A
Additional proxy soliciting materials
17 Apr 23
DEF 14A
Definitive proxy
17 Apr 23
DEFA14A
Additional proxy soliciting materials
21 Apr 22
DEF 14A
Definitive proxy
21 Apr 22
DEFA14A
Additional proxy soliciting materials
22 Apr 21
DEF 14A
Definitive proxy
22 Apr 21
DEFR14A
Revised proxy
1 May 20
DEFA14A
Additional proxy soliciting materials
23 Apr 20
Other
EFFECT
Notice of effectiveness
21 Nov 23
UPLOAD
Letter from SEC
16 Nov 23
CORRESP
Correspondence with SEC
16 Nov 23
EFFECT
Notice of effectiveness
30 Dec 20
CORRESP
Correspondence with SEC
28 Dec 20
UPLOAD
Letter from SEC
23 Dec 20
EFFECT
Notice of effectiveness
26 Jun 20
CORRESP
Correspondence with SEC
23 Jun 20
CORRESP
Correspondence with SEC
23 Jun 20
UPLOAD
Letter from SEC
18 Jun 20